StockData
PERRIGO Co plc logo

PERRIGO Co plc (PRGO) stock

PRGONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3010% below fair value
$15.76−0.42 (-2.60%)

Close on Nov 17, 2026Market cap $2.19BP/E –Yield 7.36%

Perrigo operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Perrigo's operating income for the twelve months ending Jun 27, 2026 was -$1.56B, down 644.9% year over year. For fiscal 2025 it was -$1.12B, down 1094.0% from the year before. The highest annual figure on record is $679.10M in fiscal 2013.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$1.12B-1094.0%
FY2024Dec 31, 2024$112.90M-25.7%
FY2023Dec 31, 2023$151.90M+92.5%
FY2022Dec 31, 2022$78.90M-80.8%
FY2021Dec 31, 2021$410.40M+54.8%
FY2020Dec 31, 2020$265.20M+51.8%
FY2019Dec 31, 2019$174.70M-26.1%
FY2018Dec 31, 2018$236.50M-60.5%
FY2017Dec 31, 2017$598.20M-11.0%
FY2015Jun 27, 2015$672.50M+17.7%
FY2014Jun 28, 2014$571.40M-15.9%
FY2013Jun 29, 2013$679.10M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 27, 2026$23.50M-48.2%
Q1 FY2026CQ1 2026Mar 28, 2026-$372.30M-893.8%
Q4 FY2025CQ4 2025Dec 31, 2025-$1.29B-1227.1%
Q3 FY2025CQ3 2025Sep 27, 2025$72.60M-9.7%
Q2 FY2025CQ2 2025Jun 28, 2025$45.40M–
Q1 FY2025CQ1 2025Mar 29, 2025$46.90M–
Q4 FY2024CQ4 2024Dec 31, 2024$114.20M–
Q3 FY2024CQ3 2024Sep 28, 2024$80.40M+29.5%
Q2 FY2024CQ2 2024Jun 29, 2024-$26.50M-146.7%
Q1 FY2024CQ1 2024Mar 30, 2024-$55.20M-213.8%
Q4 FY2023CQ4 2023Dec 31, 2023-$15.60M-150.3%
Q3 FY2023CQ3 2023Sep 30, 2023$62.10M+87.6%
Q2 FY2023CQ2 2023Jul 1, 2023$56.80M–
Q1 FY2023CQ1 2023Apr 1, 2023$48.50M+123.5%
Q4 FY2022CQ4 2022Dec 31, 2022$31.00M-33.6%
Q3 FY2022CQ3 2022Oct 1, 2022$33.10M-92.4%
Q2 FY2022CQ2 2022Jul 2, 2022-$6.90M–
Q1 FY2022CQ1 2022Apr 2, 2022$21.70M-57.8%
Q4 FY2021CQ4 2021Dec 31, 2021$46.70M+24.2%
Q3 FY2021CQ3 2021Oct 2, 2021$438.30M+458.3%
Q2 FY2021CQ2 2021Jul 3, 2021-$125.90M-300.8%
Q1 FY2021CQ1 2021Apr 3, 2021$51.40M-40.5%
Q4 FY2020CQ4 2020Dec 31, 2020$37.60M–
Q3 FY2020CQ3 2020Sep 26, 2020$78.50M+44.3%
Q2 FY2020CQ2 2020Jun 27, 2020$62.70M+14.0%
Q1 FY2020CQ1 2020Mar 28, 2020$86.40M-15.5%
Q4 FY2019CQ4 2019Dec 31, 2019-$37.00M-134.4%
Q3 FY2019CQ3 2019Sep 28, 2019$54.40M–
Q2 FY2019CQ2 2019Jun 29, 2019$55.00M-41.9%
Q1 FY2019CQ1 2019Mar 30, 2019$102.30M-34.5%
Q4 FY2018CQ4 2018Dec 31, 2018$107.50M-32.2%
Q3 FY2018CQ3 2018Sep 29, 2018-$122.00M-175.1%
Q2 FY2018CQ2 2018Jun 30, 2018$94.70M-36.4%
Q1 FY2018CQ1 2018Mar 31, 2018$156.30M+21.6%
Q4 FY2017CQ4 2017Dec 31, 2017$158.60M-17.5%
Q3 FY2017CQ3 2017Sep 30, 2017$162.40M-14.7%
Q2 FY2017CQ2 2017Jul 1, 2017$148.80M–
Q1 FY2017CQ1 2017Apr 1, 2017$128.50M–
Q4 FY2015CQ2 2015Jun 27, 2015$192.30M–
Q3 FY2015CQ1 2015Mar 28, 2015$190.40M–

More Perrigo figures

See a number that looks wrong?